I
Inhibikase Therapeutics, Inc. (IKT)
NCM – Real vaqt narxi. Valyuta: USD
1.91
+0.04 (2.14%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
1.92
+0.01 (0.52%)
Bozordan keyin: Jun 26, 2026, 5:21 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.91
+0.04 (2.14%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
1.92
+0.01 (0.52%)
Bozordan keyin: Jun 26, 2026, 5:21 PM EDT
This stock has a consensus price target of $5.43 based on the ratings of 8 analysts. The high is $8.00 and the low is $3.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 3 | $ 5.43 | $ 8 |
| O’zgarish | 78.57% | 223.21% | 376.19% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-06-10 | 173.22% | Oppenheimer | $5 | Initiates Coverage On | Outperform |
| 2026-03-04 | 118.58% | Ladenburg Thalmann | $4 | Initiates Coverage On | Buy |
| 2026-01-21 | 227.87% | B of A Securities | $6 | Initiates Coverage On | Buy |
| 2025-12-26 | 337.16% | HC Wainwright & Co. | $8 | Assumes | Buy |
| 2025-12-17 | 63.93% | Freedom Broker | $3 | Initiates Coverage On | Buy |